Immediate Impact
11 standout
Citing Papers
Non-small-cell lung cancer
2024 Standout
Radiomics and artificial intelligence for precision medicine in lung cancer treatment
2023 Standout
Works of Daniel French being referenced
Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN)
2022
Profiling non-small cell lung cancer reveals that PD-L1 is associated with wild type EGFR and vascular invasion, and immunohistochemistry quantification of PD-L1 correlates weakly with RT-qPCR
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel French | 146 | 128 | 42 | 24 | 253 | |
| Piotr Harbut | 105 | 52 | 19 | 19 | 254 | |
| Tatsuhiko Nishii | 166 | 167 | 22 | 18 | 289 | |
| Marco Lattuada | 160 | 98 | 62 | 17 | 321 | |
| Alen Protić | 83 | 80 | 27 | 24 | 219 | |
| Vicky Thiffault | 286 | 117 | 55 | 24 | 331 | |
| Daniel C. Oppenheimer | 67 | 77 | 94 | 18 | 231 | |
| Hayden L. Hofmann | 136 | 118 | 67 | 14 | 269 | |
| Theodoros Karaiskos | 232 | 167 | 11 | 19 | 324 | |
| Mohamed Regal | 225 | 108 | 16 | 20 | 290 | |
| Ashraf Rady | 27 | 112 | 24 | 21 | 209 |
All Works
Loading papers...